Understanding resistance mechanisms to BTK and BCL2 inhibitors in mantle cell lymphoma: implications for design of clinical trials
Rishu Agarwal, Mark A Dawson, Martin Dreyling, Constantine S Tam
Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2018
Awarded by Leukemia Lymphoma Society
M.A.D is the senior fellow for Leukaemia Foundation Australia. Research in Dawson Laboratory related to mantle cell lymphoma is supported by funding through the Leukemia Lymphoma Society (0862-15) and the National Health and Medical Research Council of Australia. RA is recipient of NHMRC Postgraduate fellowship and HSANZ Young Investigator Fellowship.